Shinzo Hiroi

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 6

Top Topics

Angiotensin Converting Enzyme

Transcription Factor

Health Promotion

Hypertensive Patients

Top Venues

Hypertension research : official journal of the Japanese Society of Hypertension

Geriatrics & gerontology international

Clinical and experimental hypertension (New York, N.Y. : 1993)

Journal of medical economics

This page only lists publications with an associated author ORCID identifier.

Publications

Ippei Morita, Kenji Kurazono, Manami Yoshida, Shinzo Hiroi, Kosuke Iwasaki, Tomomi Takeshima, Chise Ha, Ataru Igarashi
Preferences and values for government policies on infectious disease outbreaks and epidemics for the Japanese population: a conjoint analysis. Journal of medical economics (2023)
Naoki Hosogaya, Takahiro Takazono, Kenji Kurazono, Shinzo Hiroi, Kosuke Iwasaki, Tomomi Takeshima, Chise Ha, Hiroshi Mukae
Estimation of Intangible Costs for Factors Associated with Oral Antiviral Drugs for COVID-19 Treatment: A Conjoint Analysis in Japan. Advances in therapy (2023)
Shinzo Hiroi, Kiyoshi Kubota, Izumi Mishiro, Jovelle L Fernandez
Post-marketing surveillance in Japan: Potential best way forward. Pharmacoepidemiology and drug safety 26 (9) (2019)
Takayuki Ishida, Akinori Oh, Shinzo Hiroi, Yukio Shimasaki, Takuya Tsuchihashi
Current prescription status of antihypertensive drugs in Japanese patients with hypertension: Analysis by type of comorbidities. Clinical and experimental hypertension (New York, N.Y. : 1993) 41 (3) (2018)
Takayuki Ishida, Akinori Oh, Shinzo Hiroi, Yukio Shimasaki, Nobuhiro Nishigaki, Takuya Tsuchihashi
Treatment patterns and adherence to antihypertensive combination therapies in Japan using a claims database. Hypertension research : official journal of the Japanese Society of Hypertension 42 (2) (2018)
Takayuki Ishida, Akinori Oh, Shinzo Hiroi, Yukio Shimasaki, Takuya Tsuchihashi
Current use of antihypertensive drugs in Japanese patients with hypertension: Analysis by age group. Geriatrics & gerontology international 18 (6) (2018)